Shareholder Information

Shares In Issue

The number of ordinary shares of the Company in issue is 121,666,666, with approximately 56% deemed to be in public hands.

Significant Shareholders

The Company has been notified of the following interests of 5% or more in the issued ordinary share capital of the Company

 NumberOrdinary Shares %
OptiBiotix53,533,33343.99%
Seneca Partners Limited8,025,4506.60%
Stephen O'Hara6,131,4505.04%

Directors' Shareholders

 NumberOrdinary Share %
Stephen O'Hara6,131,4505.04%
Mikkel Hvid-Hansen 490,0570.41%
Adam Reynolds142,8570.12%

Restrictions on transfer of the Company's Securities

There are no restrictions on the transfer of ProBiotix Health plc's Aquis Exchange securities.

UK City Code on Takeovers and Mergers

ProBiotix Health plc is subject to the UK City Code on Takeovers and Mergers.

Other exchanges and trading platforms

ProBiotix Health plc has not applied or agreed to have any of it securities (including its Aquis Exchange securities) admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

26 July 2023Proxy results for the AGM held on 26 July 2023
  
28 June 2023Notice of Annual General Meeting held on 26 July 2023
 Proxy for the Annual General Meeting held on 26 July 2023